Related Experiment Video
Updated: Aug 23, 2026
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
[Biological markers of osteoarthritis: data from the ECHODIAH cohort]
Insights
Biological markers like CTX-II and COMP correlate with osteoarthritis symptoms and progression. High levels of urinary CTX-II and serum hyaluronic acid predict structural degeneration in osteoarthritis patients.
Area of Science:
- Biomarkers
- Osteoarthritis Research
- Connective Tissue Metabolism
Background:
- Osteoarthritis (OA) is a degenerative joint disease with complex pathophysiology.
- Identifying reliable biomarkers is crucial for monitoring OA progression and patient stratification.
- Previous research suggests various biological markers may reflect cartilage degradation and inflammation in OA.
Purpose of the Study:
- To investigate correlations between ten biological markers and clinical/radiological parameters in hip osteoarthritis (OA).
- To assess the predictive value of specific biomarkers for structural degeneration and radiological progression in OA patients.
- To explore the potential of combined biomarker assays for identifying high-risk OA individuals.
Main Methods:
- Analysis of ten biological markers from blood or urine in the ECHODIAH cohort over a 3-year follow-up.
- Multivariate analysis adjusted for age, gender, and body mass index.
- Correlation analysis with clinical (pain, function) and radiological (joint space narrowing, sclerosis) parameters.
Main Results:
- Urinary C-telopeptide of type II collagen (uCTX-II) correlated with pain, functional impairment, joint space narrowing, and subchondral sclerosis.
- Serum C-reactive protein correlated with pain; N-propeptide of type I collagen (PINP) correlated with functional impairment.
- Cartilage oligomeric matrix protein (COMP) correlated with inflammation.
- High levels of uCTX-II and serum hyaluronic acid (sAH) were associated with increased risk of structural degeneration.
Conclusions:
- Specific biological markers, including CTX-II, PINP, CRP, COMP, and sAH, show significant correlations with OA clinical and radiological features.
- uCTX-II and sAH show potential as predictive markers for OA structural degeneration and radiological progression.
- Combined assessment of uCTX-II and sAH may aid in identifying OA patients at higher risk of disease progression, warranting further investigation.
Abstract:
CORRELATIONS OF BIOLOGICAL MARKERS: Ten biological markers collected from blood or urine were analysed in the ECHODIAH cohort (patients with hip OA with a 3 Years follow up). In multivariate analysis, after adjustment for age, gender, and body mass index, some markers were found to be significantly correlated with clinical and radiological parameters. C-telopeptide of type II collagen (CTX-II) was correlated with pain, functional impairment, joint space narrowing, and subchondral sclerosis. C-reactive protein was correlated with pain. N-propeptide of type I collagen (PINP) was correlated with functional impairment, and cartilage oligomeric matrix protein (COMP) was correlated with inflammation. PREDICTIVE VALUE OF BIOLOGICAL MARKERS: High levels of urinary C-telopeptide of type II collagen (uCTX-II), a marker of cartilage degradation, and serum hyaluronic acid (sAH), a marker of synovial inflammation, were associated with higher risk of structure degeneration in osteoarthritis patients. Combined assay of these two markers could help identify patients with a higher risk of radiological progression, but many questions remain to be resolved.